34837-88-2

Basic information

• Product Name: 4-METHOXY-3-NITRO-BENZENEACETIC ACID METHYL ESTER
• Synonyms: 4-METHOXY-3-NITRO-BENZENEACETIC ACID METHYL ESTER;BENZENEACETIC ACID, 4-METHOXY-3-NITRO-, METHYL ESTER;Methyl 2-(4-methoxy-3-nitrophenyl)acetate
• CAS NO: 34837-88-2
• Molecular Formula: C₁₀H₁₁NO₅
• Molecular Weight: 225.2
• Mol File: 34837-88-2.mol
• Article Data: 6

Chemical Properties

• Melting Point: 100-102°
• Boiling Point: 356.8±27.0 °C(Predicted)
• Appearance: /
• Density: 1.264±0.06 g/cm3(Predicted)
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 4-METHOXY-3-NITRO-BENZENEACETIC ACID METHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: 4-METHOXY-3-NITRO-BENZENEACETIC ACID METHYL ESTER(34837-88-2)
• EPA Substance Registry System: 4-METHOXY-3-NITRO-BENZENEACETIC ACID METHYL ESTER(34837-88-2)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 34837-88-2(Hazardous Substances Data)

Usage

General Description

4-METHOXY-3-NITRO-BENZENEACETIC ACID METHYL ESTER is a chemical compound with the molecular formula C10H11NO5. It is a yellow crystalline solid that is commonly used in the synthesis of various organic compounds. This chemical is often employed as an intermediate in the production of pharmaceuticals, dyes, and other fine chemicals. It is also known for its use in the manufacturing of perfumes and flavorings due to its aromatic properties. Additionally, it is important to handle this compound with care, as it may pose health risks and environmental hazards if not properly managed.

Upstream product

• 67-56-1 methanol 
• 63304-80-3 (4-methoxy-3-nitrophenyl)acetic acid 
• 186581-53-3 diazomethane 
• 10463-20-4 4-hydroxy-3-nitrophenylacetic acid 
• 56245-07-9 2-(4-methoxy-3-nitrophenyl)acetonitrile 
• 6378-19-4 4-methoxy-3-nitrobenzyl chloride 
• 74-88-4 methyl iodide 
• 104-01-8 4-Methoxyphenylacetic acid 
• 61873-93-6 methyl (4-hydroxy-3-nitrophenyl)acetate 
• 156-38-7 4-hydroxyphenylacetate 
• 23786-14-3 4-methoxy-phenyl acetic acid methyl ester 

Downstream Products

• 63304-82-5 (3-amino-4-methoxy-phenyl)-acetic acid methyl ester 
• 110925-49-0 5-(2-Dipropylamino-ethyl)-2-methoxy-phenylamine 
• 110925-47-8 2-(4-methoxy-3-nitrophenyl)-N,N-dipropylethylamine 
• 383671-69-0 methyl 2-(4-methoxy-3-nitrophenyl)-2-methylpropanoate 
• 61873-93-6 methyl (4-hydroxy-3-nitrophenyl)acetate 
• 78587-72-1 methyl (3-amino-4-hydroxyphenyl)acetate 
• 134997-91-4 2-(3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)acetic acid 
• 1455471-90-5 ethyl 2-(4-(2-methoxy-2-oxoethyl)-2-nitrophenoxy)acetate 
• 866038-49-5 methyl 2-(3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)acetate 
• 63304-80-3 (4-methoxy-3-nitrophenyl)acetic acid 

Relevant articles and documents

PYRAZOLE-OXAZOLIDINONE COMPOUND FOR ANTI-HEPATITIS B VIRUS

The present invention discloses a pyrazole-oxazolidinone compound having anti-hepatitis B virus activity, which has the structure of formula (I), wherein each variable is as defined herein.

SUBSTITUTED HETEROCYCLIC ACETAMIDES AS KAPPA OPIOID RECEPTOR (KOR) AGONISTS

The present invention relates to a series of substituted compounds having the general formula (I), including their ste reoisomers and/or their pharmaceutically acceptable salts, wherein R1, R2, R3. R4, R5, and R6 are as defined herein. This invention also relates to methods of making these compounds including intermediates. The compounds of this invention are effective at the kappa (κ) opioid receptor (KOR) site. Therefore, the compounds of this invention are useful as pharmaceutical agents, especially in the treatment and/or prevention of a variety of central nervous system disorders (CNS), including but not limited to acute and chronic pain, and associated disorders, particularly functioning peripherally at the CNS.

Benzoxazepinones and their use as squalene synthase inhibitors

There is disclosed a compound represented by the formula [I]: wherein R1 is optionally substituted 1-carboxyethyl group, optionally substituted alkyl-sulfonyl group, optionally substituted (carboxy-cycloalkyl)-alkyl group, -X1-X2-Ar-X3-X4-COOH (wherein X1 and X4 are a bond or alkylene group, X2 and X3 are a bond, -O-, -S-, Ar is divalent aromatic group etc.), R2 is alkyl group optionally substituted with alkanoyloxy group and/or hydroxy group, R3 is alkyl group, and W is halogen atom, etc., or a salt thereof. The compound has the cholesterol lowering activity and the triglyceride lowering activity and is useful for preventing and/or treating hyperlipidemia.